Trusted News Discovery Since 2008
{{/content}}
Ask Dr. Nandi: FDA wants two months of safety data before considering COVID-19 vaccine
Video Credit: WXYZ Detroit
Published on October 7, 2020 - Duration: 03:13s
Ask Dr. Nandi: FDA wants two months of safety data before considering COVID-19 vaccine
There are new FDA guidelines for coronavirus vaccine developers.
Two months of follow-up data on volunteers in phase 3 trials are now needed before Emergency Use Authorization will be considered.
You are here
Related videos from verified sources
Dr. Oz Asks About Guidelines That Require Drug Manufacturers Follow Clinical Trial Participants For At Least Two Months 00:39
Video credit: CBS 62 Detroit - Published on October 12, 2020
COVID-19 vaccine not possible before election 02:14
Video credit: FOX 4 Now Florida - Published on October 7, 2020
The White House blocks new FDA guidelines 00:25
Video credit: KTNV Channel 13 Las Vegas - Published on October 6, 2020